Literature DB >> 18358324

Searching for additional disease loci in a genomic region.

Glenys Thomson1, Lisa F Barcellos, Ana M Valdes.   

Abstract

Our aim is to review methods to optimize detection of all disease genes in a genetic region. As a starting point, we assume there is sufficient evidence from linkage and/or association studies, based on significance levels or replication studies, for the involvement in disease risk of the genetic region under study. For closely linked markers, there will often be multiple associations with disease, and linkage analyses identify a region rather than the specific disease-predisposing gene. Hence, the first task is to identify the primary (major) disease-predisposing gene or genes in a genetic region, and single nucleotide polymorphisms thereof, that is, how to distinguish true associations from those that are just due to linkage disequilibrium with the actual disease-predisposing variants. Then, how do we detect additional disease genes in this genetic region? These two issues are of course very closely interrelated. No existing programs, either individually or in aggregate, can handle the magnitude and complexity of the analyses needed using currently available methods. Further, even with modern computers, one cannot study every possible combination of genetic markers and their haplotypes across the genome, or even within a genetic region. Although we must rely heavily on computers, in the final analysis of multiple effects in a genetic region and/or interaction or independent effects between unlinked genes, manipulation of the data by the individual investigator will play a crucial role. We recommend a multistrategy approach using a variety of complementary methods described below.

Mesh:

Substances:

Year:  2008        PMID: 18358324     DOI: 10.1016/S0065-2660(07)00411-7

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  12 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Genome-wide conditional search for epistatic disease-predisposing variants in human association studies.

Authors:  Gao Wang; Yaning Yang; Jurg Ott
Journal:  Hum Hered       Date:  2010-04-23       Impact factor: 0.444

3.  Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC.

Authors:  Yee Him Cheung; John Watkinson; Dimitris Anastassiou
Journal:  Hum Genet       Date:  2010-11-14       Impact factor: 4.132

4.  A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement.

Authors:  J A Hollenbach; S J Mack; P-A Gourraud; R M Single; M Maiers; D Middleton; G Thomson; S G E Marsh; M D Varney
Journal:  Tissue Antigens       Date:  2011-11

5.  Conditional asymmetric linkage disequilibrium (ALD): extending the biallelic r2 measure.

Authors:  Glenys Thomson; Richard M Single
Journal:  Genetics       Date:  2014-07-14       Impact factor: 4.562

Review 6.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

7.  Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis.

Authors:  Glenys Thomson; Nishanth Marthandan; Jill A Hollenbach; Steven J Mack; Henry A Erlich; Richard M Single; Matthew J Waller; Steven G E Marsh; Paula A Guidry; David R Karp; Richard H Scheuermann; Susan D Thompson; David N Glass; Wolfgang Helmberg
Journal:  Pac Symp Biocomput       Date:  2010

8.  Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

Authors:  David R Karp; Nishanth Marthandan; Steven G E Marsh; Chul Ahn; Frank C Arnett; David S Deluca; Alexander D Diehl; Raymond Dunivin; Karen Eilbeck; Michael Feolo; Paula A Guidry; Wolfgang Helmberg; Suzanna Lewis; Maureen D Mayes; Chris Mungall; Darren A Natale; Bjoern Peters; Effie Petersdorf; John D Reveille; Barry Smith; Glenys Thomson; Matthew J Waller; Richard H Scheuermann
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150

9.  High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.

Authors:  Lisa F Barcellos; Suzanne L May; Patricia P Ramsay; Hong L Quach; Julie A Lane; Joanne Nititham; Janelle A Noble; Kimberly E Taylor; Diana L Quach; Sharon A Chung; Jennifer A Kelly; Kathy L Moser; Timothy W Behrens; Michael F Seldin; Glenys Thomson; John B Harley; Patrick M Gaffney; Lindsey A Criswell
Journal:  PLoS Genet       Date:  2009-10-23       Impact factor: 5.917

10.  Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.

Authors:  A M Valdes; G Thomson; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-07       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.